瘤是如何逃离免疫系统的
1Boston Children's Hospital, Harvard Medical School, Boston, United States.
eLife
|May 14, 2024
概括
在β-catenin基因的突变减少从肝癌细胞的外体细胞释放. 这种降低会损害免疫细胞透到瘤中,并可能阻碍抗瘤反应.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 免疫学 免疫学 免疫学
背景情况:
- β-catenin是细胞粘附和信号通路中的一个关键蛋白质.
- 外体是细胞释放的小囊泡,在细胞间通信中起作用.
- 瘤微环境受到细胞相互作用的影响,包括免疫细胞透.
研究的目的:
- 为了研究β-catenin基因突变对肝癌细胞外体细胞释放的影响.
- 为了确定改变的外体细胞释放如何影响免疫细胞透到肝脏瘤.
主要方法:
- 在肝癌细胞系中利用β-catenin的基因突变模型.
- 从这些细胞中量化了外体细胞的产生和释放.
- 在共同培养或动物模型中评估免疫细胞 (例如T细胞) 的迁移和透.
主要成果:
- β-catenin基因的突变导致肝癌细胞对外体释放的显著减少.
- 减少的外体细胞水平与免疫细胞在瘤微环境中的透率降低相关.
- 较低的外体细胞计数与免疫细胞功能或招募功能受损有关.
结论:
- 在肝癌中,β-catenin突变破坏了外体介导的通信.
- 减少外体释放是β-catenin突变可以抑制抗瘤免疫力的机制.
- 向外体细胞的产生或功能可能是肝癌的治疗策略.
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Tumor Immunotherapy
518
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
518
Cytotoxic T Cells-mediated Immune Response
901
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
901
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cell-mediated Immune Responses
68.2K
Overview
68.2K


